pf-06700841
Showing 1 - 11 of 11
Cicatricial Alopecia Trial in New York (PF-06700841, Placebo)
Recruiting
- Cicatricial Alopecia
- PF-06700841
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 16, 2022
Healthy Female Volunteers Trial in Coral Gables, Miami (PF-06700841, Ethinyl estradiol (EE) and levonorgestrel (LN))
Completed
- Healthy Female Volunteers
- PF-06700841
- Ethinyl estradiol (EE) and levonorgestrel (LN)
-
Coral Gables, Florida
- +1 more
Nov 11, 2020
Crohn's Disease Trial in Worldwide (PF-06651600 Placebo, PF-06651600, Placebo PF-06700841)
Active, not recruiting
- Crohn's Disease
- PF-06651600 Placebo
- +3 more
-
Dothan, Alabama
- +187 more
Aug 17, 2022
Psoriatic Arthritis Trial in Worldwide (PF-06700841, Placebo)
Completed
- Psoriatic Arthritis
- PF-06700841
- Placebo
-
Maroochydore, Queensland, Australia
- +47 more
Aug 2, 2021
Heathy Participants Trial in New Haven (PF-06700841, Itraconazole)
Completed
- Heathy Participants
- PF-06700841
- Itraconazole
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Jan 28, 2020
Atopic Dermatitis Trial in Worldwide (PF-06700841, Vehicle (Placebo))
Completed
- Atopic Dermatitis
- PF-06700841
- Vehicle (Placebo)
-
Birmingham, Alabama
- +75 more
Mar 3, 2021
Healthy Trial in Brussels (PF-06700841, Placebo, moxifloxacin)
Completed
- Healthy
- PF-06700841
- +2 more
-
Brussels, BelgiumPfizer Clinical Research Unit
Feb 25, 2019
Chronic Plaque Psoriasis Trial in Canada, Poland, United States (PF-06700841, Placebo)
Completed
- Chronic Plaque Psoriasis
- PF-06700841
- Placebo
-
Rogers, Arkansas
- +43 more
Mar 28, 2019
Healthy Trial in Brussels (PF-06700841, Placebo)
Completed
- Healthy
- PF-06700841
- Placebo
-
Brussels, BelgiumPfizer Clinical Research Unit
Oct 23, 2017